Patent details

EP3350318 Title: METHODS RELATING TO ACTIVATED DENDRITIC CELL COMPOSITIONS FOR SUBJECTS WITH ADVANCED CANCERS

Basic Information

Publication number:
EP3350318
PCT Application Number:
US2016051781
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP168472538
PCT Publication Number:
WO2017048875
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS RELATING TO ACTIVATED DENDRITIC CELL COMPOSITIONS FOR SUBJECTS WITH ADVANCED CANCERS
French Title of Invention:
PROCÉDÉS RELATIFS À DES COMPOSITIONS DE CELLULES DENDRITIQUES ACTIVÉES POUR DES SUJETS ATTEINTS DE CANCERS AVANCÉS
German Title of Invention:
VERFAHREN IM ZUSAMMENHANG MIT AKTIVIERTEN DENDRITISCHEN ZELLZUSAMMENSETZUNGEN FÜR PERSONEN MIT FORTGESCHRITTENEN KREBSERKRANKUNGEN
SPC Number:

Dates

Filing date:
14/09/2016
Grant date:
13/04/2022
EP Publication Date:
25/07/2018
PCT Publication Date:
23/03/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/04/2022
EP B1 Publication Date:
13/04/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/09/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/04/2022
 
 

Name:
NorthWest Biotherapeutics, Inc.
Address:
4800 Montgomery Lane, Suite 800, Bethesda, MD 20814, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
30/06/2022
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
BOSCH, Marnix, L.
Address:
United States (US)

Priority

Priority Number:
201562219058 P
Priority Date:
15/09/2015
Priority Country:
United States (US)

Classification

IPC classification:
C12N 5/0784; C12N 5/02; C07K 14/535; C07K 14/54; C07K 14/57; C07K 14/525; A61K 35/15; G01N 33/50; G01N 33/569; G01N 33/68;

Publication

European Patent Bulletin

Issue number:
202215
Publication date:
13/04/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/09/2025
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Expected Payer:
Last Annual Fee Payment Date:
11/03/2025
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
UAB NIUM EU + patentrenewal com ApS
Filing date Document type Number of pages
30/06/2022 Power Of Attorney 1
30/06/2022 Outgoing Correspondence 1